Angiotensin-converting enzyme inhibitors (ACEIs) are considered the first-line treatment for hypertension in individuals with T1DM, with angiotensin II receptor blockers (ARBs) being an alternative option for patients who are intolerant of ACEIs [14]. Here, ACE is linked to hypertensive disorder.